Merrimack Pharmaceuticals Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$4.59 |
Market Cap |
$77.52 M |
Shares Outstanding |
13.34 M |
Public Float |
11.22 M |
Address |
One Broadway Cambridge Massachusetts 02142 United States |
Employees | - |
Website | http://www.merrimackpharma.com |
Updated | 07/08/2019 |
Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310. The company was founded by Anthony J. |